Background: Lymphocytic hypophysitis is a disorder of the pituitary gland that presents as a sellar mass lesion and/or hypopituitarism. It causes pituicyte destruction and hypopituitarism and is speculated to have an autoimmune basis. Diagnosis: Lymphocytic hypophysitis should be considered in the differential diagnosis of pituitary masses and/or hypopituitarism in females who are pregnant or in the early postpartum period, especially in cases associated with other autoimmune diseases or unusual patterns of hormone deficiencies. A definitive diagnosis requires tissue biopsy. A presumptive clinical diagnosis can be made based on a history of gestational or postpartum hypopituitarism, a contrast-enhancing sellar mass with imaging features characteristic of lymphocytic hypophysitis, a pattern of pituitary hormone deficiency with early loss of adrenocorticotrophic hormone and thyroid-stimulating hormone unlike that typically found with macroadenomas, relatively rapid development of hypopituitarism and a degree of pituitary failure disproportionate to the size of the mass.Symptoms resulting from partial or panhypopituitarism occur in approximately 80% of cases and multiple deficiencies are found in approximately 75% of cases. Management: Appropriate management remains controversial. Corticosteroid therapy has been advocated as a means of attenuating inflammation, but given the uncertainty of its efficacy and the known adverse effects, such therapy does not seem justified for most patients. The optimal surgical strategy involves partial resection of the mass to decompress the surrounding structures. All patients with lymphocytic hypophysitis require appropriate replacement therapy for deficient hormones. Long-term follow-up is mandatory to monitor for the development of other hormonal deficits.

Keywords:
Lymphocytic hypophysitis, Sellar mass, Hypopituitarism, Pregnancy
1.
Goudie R, Pinkerton P: Anterior hypophysitis and Hashimoto’s disease in a young woman. J Pathol Bacteriol 1962;83:584–585.
2.
Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A: Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 2003;149:363–376.
3.
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR: Autoimmune hypophysitis. Endocr Rev 2005;26:599–614.
4.
Lury KM: Inflammatory and infectious processes involving the pituitary gland. Top Magn Reson Imaging 2005;16:301–306.
5.
Rivera J-A: Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary 2006;9:35–45.
6.
Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H: Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med 1993;329:683–689.
7.
Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S: Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 1995;80:2302–2311.
8.
Cosman F, Post KD, Holub DA, Wardlaw SL: Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine 1989;68:240–256.
9.
Gutenberg A, Buslei R, Fahlbusch R, Buchfelder M, Bruck W: Immunopathology of primary hypophysitis. Implications for pathogenesis. Am J Surg Pathol 2005;29:329–338.
10.
Kelly WF, Bradey N, Scoones D: Rosai-Dorfman disease presenting as a pituitary tumour. Clin Endocrinol 1999;50:133–137.
11.
Olmos PR, Falko JM, Rea GL, Boesel CP, Chakeres DW, McGhee DB: Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery 1993;32:1015–1021.
12.
Hama S, Arita K, Kurisu K, Sumida M, Kurihara K: Parasellar chronic inflammatory disease presenting Tolosa-Hunt syndrome, hypopituitarism and diabetes insipidus: a case report. Endocr J 1996;43:503–510.
13.
Hansen I, Petrossians P, Thiry A, Flandroy P, Gaillard RC, Kovacs K, Claes F, Stevenaert A, Piguet P, Beckers A: Extensive inflammatory pseudotumor of the pituitary. J Clin Endocrinol Metab 2001;86:4603–4610.
14.
Muir A, Maclaren NK: Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis. Endocrinol Metab Clin North Am 1991;20:619–644.
15.
Bottazzo GF, Pouplard A, Florin-Christensen A, Doniach D: Autoantibodies to prolactin-secreting cells of human pituitary. Lancet 1975;2:97–101.
16.
Castle D, de Villiers JC, Melvill R: Lymphocytic adenohypophysitis. Report of a case with demonstration of spontaneous tumour regression and a review of the literature. Br J Neurosurg 1988;2:401–405.
17.
Levine S: Allergic adenohypophysitis: new experimental disease of the pituitary gland. Science 1967;158:1190–1191.
18.
Levine S: Allergic adrenalitis and adenohypophysitis: further observations on production and passive transfer. Endocrinology 1969;84:469–475.
19.
Klein I, Kraus KE, Martines AJ, Weber S: Evidence for cellular mediated immunity in an animal model of autoimmune pituitary disease. Endocr Res Commun 1982;9:145–153.
20.
Yoon JW, Choi DS, Liang HC, Baek HS, Ko IY, Jun HS, Gillam S: Induction of an organ-specific autoimmune disease, lymphocytic hypophysitis, in hamsters by recombinant rubella virus glycoprotein and prevention of disease by neonatal thymectomy. J Virol 1992;66:1210–1214.
21.
Bottazzo GF, Doniach D: Pituitary autoimmunity: a review. J R Soc Med 1978;71:433–436.
22.
Crock PA: Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 1998;83:609–618.
23.
Komatsu M, Kondo T, Yamauchi K, Yokokawa N, Ichikawa K, Ishihara M, Aizawa T, Yamada T, Imai Y, Tanaka K: Antipituitary antibodies in patients with the primary empty sella syndrome. J Clin Endocrinol Metab 1988;67:633–638.
24.
Scherbaum WA, Schrell U, Gluck M, Fahlbusch R, Pfeiffer EF: Autoantibodies to pituitary corticotropin-producing cells: possible marker for unfavourable outcome after pituitary microsurgery for Cushing’s disease. Lancet 1987;1:1394–1398.
25.
Engelberth O, Jezkova Z, Bleha O, Málek J, Bendl J: [Autoantibodies in Sheehan’s syndrome]. Vnitr Lek 1965;11:737–741.
26.
Beressi N, Beressi JP, Cohen R, Modigliani E: Lymphocytic hypophysitis. A review of 145 cases. Ann Med Intern 1999;150:327–341.
27.
Nussbaum CE, Okawara SH, Jacobs LS: Lymphocytic hypophysitis with involvement of the cavernous sinus and hypothalamus. Neurosurgery 1991;28:440–444.
28.
Ikeda J, Kuratsu J, Miura M, Kai Y, Ushio Y: Lymphocytic adenohypophysitis accompanying occlusion of bilateral internal carotid arteries – case report. Neurol Med Chir (Tokyo) 1990;30:346–349.
29.
Cebelin MS, Velasco ME, de las Mulas JM, Druet RL: Galactorrhea associated with lymphocytic adenohypophysitis. Case report. Br J Obstet Gynaecol 1981;88:675–680.
30.
Portocarrero CJ, Robinson AG, Taylor AL, Klein I: Lymphoid hypophysitis. An unusual cause of hyperprolactinemia and enlarged sella turcica. JAMA 1981;246:1811–1812.
31.
Pressman EK, Zeidman SM, Reddy UM, Epstein JI, Brem H: Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient. J Reprod Med 1995;40:251–259.
32.
Saiwai S, Inoue Y, Ishihara T, Matsumoto S, Nemoto Y, Tashiro T, Hakuba A, Miyamoto T: Lymphocytic adenohypophysitis: skull radiographs and MRI. Neuroradiology 1998;40:114–120.
33.
Ishihara T, Hino M, Kurahachi H, Kobayashi H, Kajikawa M, Moridera K, Ikekubo K, Hattori N: Long-term clinical course of two cases of lymphocytic adenohypophysitis. Endocr J 1996;43:433–440.
34.
Kojima H, Nojima T, Nagashima K, Ono Y, Kudo M, Ishikura M: Diabetes insipidus caused by lymphocytic infundibuloneurohypophysitis. Arch Pathol Lab Med 1989;113:1399–1401.
35.
Shimono T, Yamaoka T, Nishimura K, Koshiyama H, Sakamoto M, Koh T, Hayakawa K: Lymphocytic hypophysitis presenting with diabetes insipidus: MR findings. Eur Radiol 1999;9:1397–1400.
36.
Nishioka H, Ito H, Sano T, Ito Y: Two cases of lymphocytic hypophysitis presenting with diabetes insipidus: a variant of lymphocytic infundibulo-neurohypophysitis. Surg Neurol 1996;46:285–290.
37.
Castle D, de Villiers JC, Melvill R: Lymphocytic adenohypophysitis. Report of a case with demonstration of spontaneous tumour regression and a review of the literature. Br J Neurosurg 1988;2:401–405.
38.
Zeller JR, Cerletty JM, Rabinovitch RA, Daniels D: Spontaneous regression of a postpartum pituitary mass demonstrated by computed tomography. Arch Intern Med 1982;142:373–374.
39.
Leiba S, Schindel B, Weinstein R, Lidor I, Friedman S, Matz S: Spontaneous postpartum regression of pituitary mass with return of function. JAMA 1986;255:230–232.
40.
Feigenbaum SL, Martin MC, Wilson CB, Jaffe RB: Lymphocytic adenohypophysitis: a pituitary mass lesion occurring in pregnancy. Proposal for medical treatment. Am J Obstet Gynecol 1991;164:1549–1555.
41.
Kristof RA, Van Roost D, Klingmuller D, Springer W, Schramm J: Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy? J Neurol Neurosurg Psychiatry 1999;67:398–402.
42.
Tsur A, Leibowitz G, Samueloff A, Gross DJ: Successful pregnancy in a patient with pre-existing lymphocytic hypophysitis. Acta Obstet Gynecol Scand 1996;75:772–774.
43.
Reusch JE, Kleinschmidt-DeMasters BK, Lillehei KO, Rappe D, Gutierrez-Hartmann A: Preoperative diagnosis of lymphocytic hypophysitis (adenohypophysitis) unresponsive to short course dexamethasone: case report. Neurosurgery 1992;30:268–272.
44.
Nishioka H, Ito H, Miki T, Akada K: A case of lymphocytic hypophysitis with massive fibrosis and the role of surgical intervention. Surgical Neurol 1994;42:74–78.
45.
Mayfield RK, Levine JH, Gordon L, Powers J, Galbraith RM, Rawe SE: Lymphoid adenohypophysitis presenting as a pituitary tumor. Am J Med 1980;69:619–623.
46.
Parent AD: The course of lymphocytic hypophysitis [letter; comment]. Surgical Neurol 1992;37:71.
47.
Beressi N, Cohen R, Beressi JP, Dumas J-L, Legrand M, Iba-Zizen M-T, Modigliani E: Pseudotumoral lymphocytic hypophysitis successfully treated by corticosteroid alone: first case report. Neurosurgery 1994;35:505–508.
48.
Gagneja H, Arafah B, Taylor HC: Histologically proven lymphocytic hypophysitis: spontaneous resolution and subsequent pregnancy. Mayo Clin Proc 1999;74:150–154.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.